Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 314 for infectious diseases

Edit search filters
  1. Prevalence and Predictors of Spike Protein Antibodies in COVID-19 Vaccinated Individuals

    Jacksonville, FL

  2. A Study to Assess International SARS-CoV-2 (COVID-19) Infection

    Rochester, MN

  3. A Study to Assess the Burden of Respiratory Syncytial Virus Infections in Older Adults in a North American Community

    Rochester, MN

  4. A COVID Study to Compare Impact of Zinc Supplementation versus Multivitamin to Support Immune Health

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. A Study to Compare COVID-19 Nasal Testing to Gastric, Bile, or Intestinal Testing

    Rochester, MN

  6. A Study to Compare BAL CD8+ TRM Cells and Lung Fibrosis Scores in COVID-19 Infection Survivors

    Rochester, MN

  7. A Study to Compare Nasal Swabs to Detect Severe Acute Respiratory Syndrome Coronavirus 2

    Rochester, MN

  8. Mayo Clinic COVID-19 Pandemic Response Stool Biobank (Prospective)

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  9. Evaluation of the Effects of Caffeine, Via the ACE2 Receptor, on Clinical Severity of COVID-19 Disease

    Jacksonville, FL

  10. T Cell Response to COVID19 Vaccinated Individuals

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer